Prelude Capital Management’s Biote Corp BTMD Stock Holding History

Prelude Capital Management’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26,191	Closed	-$162K	–	1141
2023 Q1	$162K	Sell	26,191 -61,335	-70%	-$275K	0.01%	901
2022 Q4	$326K	Sell	87,526 -3,828	-4%	-$16K	0.02%	763
2022 Q3	$391K	Buy	91,354 +25,170	+38%	+$107K	0.01%	754
2022 Q2	$250K	Sell	66,184 -213,354	-76%	-$1.68M	0.01%	1161
2022 Q1	$2.76M	Buy	279,538 +20,000	+8%	+$197K	0.08%	243
2021 Q4	$2.54M	Buy	259,538 +1,538	+0.6%	+$15K	0.07%	248
2021 Q3	$2.51M	Hold	258,000	–	–	0.06%	239
2021 Q2	$2.5M	Buy	+258,000	New	+$2.53M	0.07%	228

Other funds holding BTMD

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Bandera Partners New York $284M AUM 33.52% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VCM

Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Prelude Capital Management's BTMD Position: Q2 2023 in Review

Prelude Capital Management sold out of Biote Corp (BTMD) in Q2 2023, closing a stake of 26,191 shares — an estimated $162K sold.

Prelude Capital Management first reported a position in BTMD in Q2 2021 and held it in 8 quarters. The position peaked at $2.76M in Q1 2022. 55 funds tracked by Wall St. Rank hold BTMD as of Q2 2023.

Prelude Capital Management reported no remaining Biote Corp position as of Q2 2023 after selling out during the quarter.
Prelude Capital Management sold 26,191 Biote Corp shares in Q2 2023, an estimated $162K.
Prelude Capital Management first reported a position in Biote Corp in Q2 2021 and held it in 8 quarters.
Prelude Capital Management's Biote Corp position peaked at $2.76M in Q1 2022.
55 funds tracked by Wall St. Rank held Biote Corp as of Q2 2023.

Based on Prelude Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.